2008
Estimation of HIV Incidence in the United States
Hall HI, Song R, Rhodes P, Prejean J, An Q, Lee LM, Karon J, Brookmeyer R, Kaplan EH, McKenna MT, Janssen RS, Group F. Estimation of HIV Incidence in the United States. JAMA 2008, 300: 520-529. PMID: 18677024, PMCID: PMC2919237, DOI: 10.1001/jama.300.5.520.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virusHIV incidenceHIV infectionBED HIV-1 capture enzyme immunoassayIncidence of HIVNew infectionsPatients 13 yearsNew HIV infectionsPercent of infectionsClinic-based settingBlack individualsCapture enzyme immunoassayHIV diagnosisHIV casesImmunodeficiency virusRecent infectionIncidence rateMAIN OUTCOMEDiagnostic seraAIDS incidenceDisease controlInfectionEnzyme immunoassayIncidenceDiagnostic specimens
2005
Operational effectiveness of suicide-bomber-detector schemes: A best-case analysis
Kaplan EH, Kress M. Operational effectiveness of suicide-bomber-detector schemes: A best-case analysis. Proceedings Of The National Academy Of Sciences Of The United States Of America 2005, 102: 10399-10404. PMID: 15998738, PMCID: PMC1177362, DOI: 10.1073/pnas.0500567102.Peer-Reviewed Original Research
2004
Detecting Bioterror Attack - Volume 10, Number 8—August 2004 - Emerging Infectious Diseases journal - CDC
Bicout D, Kaplan E, Wein L. Detecting Bioterror Attack - Volume 10, Number 8—August 2004 - Emerging Infectious Diseases journal - CDC. Emerging Infectious Diseases 2004, 10: 1504b-1505. PMID: 15503398, PMCID: PMC3320411, DOI: 10.3201/eid1008.031044.Peer-Reviewed Original Research
2003
Emergency response to an anthrax attack
Wein LM, Craft DL, Kaplan EH. Emergency response to an anthrax attack. Proceedings Of The National Academy Of Sciences Of The United States Of America 2003, 100: 4346-4351. PMID: 12651951, PMCID: PMC153095, DOI: 10.1073/pnas.0636861100.Peer-Reviewed Original Research
2001
Public Health Consequences of Screening Patients for Adherence to Highly Active Antiretroviral Therapy
Tchetgen E, Kaplan E, Friedland G. Public Health Consequences of Screening Patients for Adherence to Highly Active Antiretroviral Therapy. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2001, 26: 118-129. DOI: 10.1097/00126334-200102010-00003.Peer-Reviewed Original ResearchConceptsActive antiretroviral therapyAntiretroviral therapyDrug resistanceDrug-resistant virusesNew HIV infectionsHIV antiretroviral therapyImportance of adherencePublic health consequencesHIV patientsHIV infectionTreatment regimensScreening patientsAIDS casesPatient benefitPhysician's abilityPatientsAIDS incidenceTherapyHealth consequencesAdherenceRecent studiesPopulation levelHAARTRegimensHIVPublic Health Consequences of Screening Patients for Adherence to Highly Active Antiretroviral Therapy
Tchetgen E, Kaplan E, Friedland G. Public Health Consequences of Screening Patients for Adherence to Highly Active Antiretroviral Therapy. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2001, 26: 118-129. PMID: 11242178, DOI: 10.1097/00042560-200102010-00003.Peer-Reviewed Original ResearchConceptsActive antiretroviral therapyAntiretroviral therapyDrug resistanceDrug-resistant virusesNew HIV infectionsHIV antiretroviral therapyImportance of adherencePublic health consequencesHIV patientsHIV infectionTreatment regimensScreening patientsAIDS casesPatient benefitPhysician's abilityPatientsAIDS incidenceTherapyHealth consequencesAdherenceRecent studiesPopulation levelHAARTRegimensHIV
2000
Treatment on demand: an operational model
Kaplan E, Johri M. Treatment on demand: an operational model. Health Care Management Science 2000, 3: 171-183. PMID: 10907320, DOI: 10.1023/a:1019001726188.Peer-Reviewed Original ResearchRepeat Screening for HIV: When to Test and Why
Kaplan E, Satten G. Repeat Screening for HIV: When to Test and Why. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2000, 23: 339-345. DOI: 10.1097/00042560-200004010-00010.Peer-Reviewed Original ResearchRepeat screening for HIV: when to test and why.
Kaplan E, Satten G. Repeat screening for HIV: when to test and why. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2000, 23: 339-45. PMID: 10836757, DOI: 10.1097/00126334-200004010-00010.Peer-Reviewed Original Research
1999
Hold everything! Holding policies for protecting plasma supplies
Kaplan E, Satten G. Hold everything! Holding policies for protecting plasma supplies. Mathematical Biosciences 1999, 160: 159-173. PMID: 10472752, DOI: 10.1016/s0025-5564(99)00033-4.Peer-Reviewed Original ResearchNew approaches to HIV surveillance: means and ends. Summary report of conference held at Yale University, 21-22 May 1998, by the Law, Policy and Ethics Core, Center for Interdisciplinary Research on AIDS, Yale University.
Johri M, Kaplan E, Levi J, Novick A. New approaches to HIV surveillance: means and ends. Summary report of conference held at Yale University, 21-22 May 1998, by the Law, Policy and Ethics Core, Center for Interdisciplinary Research on AIDS, Yale University. AIDS & Public Policy Journal 1999, 14: 136-46. PMID: 11148944.Peer-Reviewed Original ResearchCenters for Disease Control and Prevention, U.S.ConfidentialityContact TracingData CollectionData Interpretation, StatisticalDisease NotificationForecastingHIV InfectionsHumansIncidenceMandatory TestingMass ScreeningMedical Record LinkageOrganizational ObjectivesPopulation SurveillancePrevalenceReproducibility of ResultsUnited States
1998
To treat or not to treat?
Kaplan E. To treat or not to treat? Nature Medicine 1998, 4: 664-665. PMID: 9623969, DOI: 10.1038/nm0698-664.Peer-Reviewed Original ResearchA mathematical model of HIV transmission in NSW prisons
Dolan K, Wodak A, Hall W, Kaplan E. A mathematical model of HIV transmission in NSW prisons. Drug And Alcohol Dependence 1998, 50: 197-202. PMID: 9649972, DOI: 10.1016/s0376-8716(98)00009-x.Peer-Reviewed Original ResearchHIV Incidence in Ethiopian Immigrants to Israel
Kaplan E, Kedem E, Pollack S. HIV Incidence in Ethiopian Immigrants to Israel. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1998, 17: 465-469. PMID: 9562050, DOI: 10.1097/00042560-199804150-00012.Peer-Reviewed Original ResearchIsrael's ban on use of Ethiopians' blood: how many infectious donations were prevented?
Kaplan E. Israel's ban on use of Ethiopians' blood: how many infectious donations were prevented? The Lancet 1998, 351: 1127-1128. PMID: 9660600, DOI: 10.1016/s0140-6736(97)10356-7.Peer-Reviewed Original Research
1996
In Vitro Fertilization Patient Population on Which to Base Predictive Testing?
McDonough P, Kaplan E. In Vitro Fertilization Patient Population on Which to Base Predictive Testing? Fertility And Sterility 1996, 66: 164-166. PMID: 8752633, DOI: 10.1016/s0015-0282(16)58409-x.Peer-Reviewed Original Research
1995
HIV Incidence Among New Haven Needle Exchange Participants
Kaplan E, Heimer R. HIV Incidence Among New Haven Needle Exchange Participants. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1995, 10: 175-176. PMID: 7552482, DOI: 10.1097/00042560-199510020-00010.Peer-Reviewed Original ResearchEconomic analysis of needle exchange
Kaplan E. Economic analysis of needle exchange. AIDS 1995, 9: 1113-1120. PMID: 8519446, DOI: 10.1097/00002030-199510000-00001.Peer-Reviewed Original Research
1994
A method for evaluating needle exchange programmes
Kaplan E. A method for evaluating needle exchange programmes. Statistics In Medicine 1994, 13: 2179-2187. PMID: 7846418, DOI: 10.1002/sim.4780131923.Peer-Reviewed Original ResearchA circulation theory of needle exchange
Kaplan E, Heimer R. A circulation theory of needle exchange. AIDS 1994, 8: 567-574. PMID: 8060540, DOI: 10.1097/00002030-199405000-00001.Peer-Reviewed Original Research